Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ)
Antibodies and antigen binding fragments thereof that bind to human protein tyrosine phosphatase beta (HPTPβ), and uses thereof.
1. An isolated antibody or antigen-binding fragment thereof which binds to human protein tyrosine phosphatase beta (HPTPβ), wherein said antibody or antigen-binding fragment thereof regulates angiogenesis.
2. The antibody or antigen-binding fragment thereof according to claim 1 , wherein the antibody or antigen-binding fragment thereof binds the N-terminal portion of HPTPβ.
3. The antibody or antigen-binding fragment thereof according to claim 2 , wherein the antibody or antigen-binding fragment thereof binds the first FN3 repeat of HPTPβ.
4. The antibody or antigen-binding fragment thereof according to claim 3 , wherein the first FN3 repeat of HPTPβ has the sequence as shown in SEQ ID NO:11.
5. The antibody or antigen-binding fragment thereof according to claim 1 , wherein the antibody is a monoclonal antibody or antigen-binding fragment thereof.
6. The monoclonal antibody according to claim 5 produced by hybridoma cell line ATCC No. PTA-7580 or the antigen-binding fragment of the monoclonal antibody according to claim 5 produced by hydriboma cell line ATCC No. PTA-7580.
7. The antibody or antigen binding fragment thereof according to claim 1 , wherein the antibody or antigen binding fragment thereof is humanized.
8. The antibody or antigen-binding fragment thereof according to claim 6 , which comprises antigen binding region residues from the monoclonal antibody R15E6, ATCC No. PTA-7580, and is humanized.
9. The antigen binding fragment according to claim 7 , wherein the fragment comprises heavy and light chain variable regions.
10. An antigen binding fragment according to claim 7 , wherein the antigen-binding fragment is selected from the group consisting of an Fv fragment, and Fab fragment, an Fab' fragment, and an F(ab') 2 fragment.
11. The monoclonal antibody R15E6, produced by hybridoma cell line ATCC No. PTA-7580 which binds to human protein tyrosine phosphatase beta (HPTPβ).
12. A pharmaceutical composition, comprising:
a. the antibody or antigen-binding fragment thereof according to claim 1 , and
b. a pharmaceutically acceptable carrier.
13. A pharmaceutical composition, comprising:
a. the antibody or antigen-binding fragment thereof according to claim 6 , and
b. a pharmaceutically acceptable carrier.
14. A pharmaceutical composition, comprising:
a. the antibody or antigen-binding fragment thereof according to claim 7 , and
b. a pharmaceutically acceptable carrier.
15. A pharmaceutical composition, comprising:
a. the antibody or antigen-binding fragment thereof according to claim 8 , and
b. a pharmaceutically acceptable carrier.
16. A pharmaceutical composition, comprising:
a. the antibody according to claim 11 or a fragment thereof; and
b. a pharmaceutically acceptable carrier.